Attention-Deficit–Hyperactivity Disorder (ADHD): Bridging Theory and Clinical Application
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Mental Health".
Deadline for manuscript submissions: 25 March 2026 | Viewed by 6526
Special Issue Editor
Special Issue Information
Dear Colleagues,
Journal of Clinical Medicine is pleased to announce a Special Issue dedicated to attention-deficit–hyperactivity disorder (ADHD), bridging theory and clinical application. Despite significant advances in ADHD research, the practical implementation of these findings in clinical settings remains a challenge. Therefore, we invite contributions that integrate theoretical insights with real-world strategies for the diagnosis, treatment, and management of ADHD across diverse populations.
The aims of this Special Issue include the following:
- To bridge theoretical insights and clinical application: Translating current research findings into actionable interventions and best practices.
- To highlight interdisciplinary approaches: Encouraging collaboration among neuroscience, psychology, and pharmacology to address the multifaceted nature of ADHD.
- To address gaps in current knowledge: Advancing the understanding of underexplored areas of ADHD, from novel diagnostic methods to innovative therapeutic modalities.
Submissions may include, but are not limited to, the following areas:
- Diagnosis and Assessment:
- Innovations in diagnostic criteria and tools, with attention to adult and older populations;
- Diagnostic challenges among underrepresented groups, including individuals with intellectual disabilities;
- Comorbid conditions and their effect on diagnostic accuracy.
- Emotional Dysregulation and Neurobiology:
- Interactions between emotional dysregulation and core ADHD symptoms;
- The role of the cortico-striatal network and neurotransmitter systems.
- Pharmacological and Non-Pharmacological Treatments:
- Advances in stimulant and non-stimulant therapies;
- Long-term outcomes and safety of ADHD medications;
- Psychostimulants’ impact on sleep, emotional regulation, and cognitive functioning.
- ADHD Across the Lifespan:
- The developmental trajectories and persistence of ADHD symptoms;
- Unique treatment considerations for older adults;
- Interaction between ADHD and age-related conditions.
- Comorbidities and Special Populations:
- ADHD with co-occurring psychiatric conditions (e.g., anxiety, depression, substance use);
- ADHD within neurodevelopmental disorders (e.g., autism spectrum disorder, intellectual disabilities);
- Sex and gender differences in ADHD presentation and management.
We encourage authors from diverse disciplines and international settings to share their latest work shaping the future of ADHD research and practice. By bringing together evidence-based insights and clinical innovations, the ultimate aim of this Special Issue is to foster meaningful progress in the field. We welcome original research, reviews, systematic reviews, meta-analyses, and other scholarly contributions.
We look forward to your contributions and thank you in advance for partnering with us to advance knowledge and improve care for individuals with ADHD. For further inquiries or to submit your manuscript, please visit the journal’s website or contact the Special Issue Guest Editor directly.
Dr. Rafał R. Jaeschke
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- ADHD
- emotional dysregulation
- diagnosis and assessment
- pharmacological and non-pharmacological treatments
- neurobiology
- comorbidities
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
